Scan barcode

150 pages • missing pub info (editions)
ISBN/UID: 9780309310000
Format: Paperback
Language: English
Publisher: National Academies Press
Publication date: 19 January 2015
Description
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and lim...
Community Reviews
Content Warnings

150 pages • missing pub info (editions)
ISBN/UID: 9780309310000
Format: Paperback
Language: English
Publisher: National Academies Press
Publication date: 19 January 2015
Description
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and lim...